Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$697,937
in 4 filings, $698K under 10b5-1 plans

Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-06-07 Hopkinson Craig C. SVP, Med Dev/Med Affairs, CMO Exercise or conversion · Restricted Stock Unit Award −1,250 3,750
2018-06-01 MITCHELL PAUL J Director Exercise or conversion +1,000 $8.98 $9K 1,000
2018-06-01 MITCHELL PAUL J Director Sale −1,000 $47.34 $47K 0
2018-06-01 MITCHELL PAUL J Director Exercise or conversion · Non Qualified Stock Option (Right to Buy) −1,000 17,000
2018-05-24 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Exercise or conversion +20,000 $12.29 $246K 192,644
2018-05-24 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Sale −20,000 $45.22 $904K 172,644
2018-05-24 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Exercise or conversion · Employee Stock Option (Right to Buy) −20,000 0
2018-05-23 Wysenski Nancy Director Grant or award · Non Qualified Stock Option (Right to Buy) +17,500 17,500
2018-05-23 snyderman nancy lynn MD Director Grant or award · Non Qualified Stock Option (Right to Buy) +17,500 17,500
2018-05-23 BLOOM FLOYD E Director Grant or award · Non Qualified Stock Option (Right to Buy) +17,500 17,500
2018-05-23 DIXON WENDY L Director Grant or award · Non Qualified Stock Option (Right to Buy) +17,500 17,500
2018-05-23 BREYER ROBERT A Director Grant or award · Non Qualified Stock Option (Right to Buy) +17,500 17,500
2018-05-23 MITCHELL PAUL J Director Grant or award · Non Qualified Stock Option (Right to Buy) +17,500 17,500
2018-05-23 Cooke Shane Director Grant or award · Non Qualified Stock Option (Right to Buy) +17,500 17,500
2018-05-23 Cooke Shane Director Grant or award · Non Qualified Stock Option (Right to Buy) +26,000 26,000
2018-05-23 ANSTICE DAVID W Director Grant or award · Non Qualified Stock Option (Right to Buy) +17,500 17,500
2018-05-22 POPS RICHARD F Director and CEO, Alkermes plc Exercise or conversion +20,000 $12.29 $246K 686,352
2018-05-22 POPS RICHARD F Director and CEO, Alkermes plc Sale −16,318 $45.33 $740K 670,034
2018-05-22 POPS RICHARD F Director and CEO, Alkermes plc Sale −3,682 $46.03 $169K 666,352
2018-05-22 POPS RICHARD F Director and CEO, Alkermes plc Exercise or conversion · Employee Stock Option (Right to Buy) −20,000 0

Page 89 of 90 · 1,796 trades